Ausgabe 1/2018
Inhalt (7 Artikel)
Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review
Alemayehu B. Mekonnen, Tariq M. Alhawassi, Andrew J. McLachlan, Jo-anne E. Brien
Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases
Jason C. Simeone, Beth L. Nordstrom, Kwame Appenteng, Samuel Huse, Milbhor D’Silva
Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study
Jörg Mahlich, Sunny Tsukazawa, Frank Wiegand
Contact Dermatitis after Prescription of an Ophthalmic Ointment Containing Fradiomycin Sulfate: A Retrospective Database Study Using Japanese Health Insurance Claims Data
Naomi Sugimoto, Kazuhiko Kuribayashi, Yuji Yamamoto, Satoshi Nagayasu, Osamu Suga, Yoko Fujimoto
Quantitative Testing of Prescriber Knowledge Regarding the Risks and Safe Use of Albiglutide
Carol Koro, Janet Pientka, Veronica Bainbridge, Natalie O’Donnell, Monika Stender, Annette Stemhagen
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?
Kathleen A. Fairman, Lindsay E. Davis, Alyssa M. Peckham, David A. Sclar
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
Marie-Hélène Lafeuille, Neeta Tandon, Sean Tiggelaar, Rhiannon Kamstra, Patrick Lefebvre, Edward Kim, Yong Yue, Kruti Joshi